Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the ...

Cencora (NYSE:COR) has made headlines with its announcement on March 10, 2025, detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth.

Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going ...

With a market cap of $50.5 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions ...

COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

In a recent 8-K filing with the Securities and Exchange Commission, Cencora, Inc., a Delaware-based company in the wholesale drug industry and a prominent player in Healthcare Providers & Services ...

In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against other stocks with at least $30 million in insider sales recently. Last week, stocks declined in part ...

We recently published a list of Top 10 Stocks Analysts are Watching as AI Selloff Deepens. In this article, we are going to ...

Fisher Asset Management LLC boosted its stake in shares of Cencora, Inc. (NYSE:COR – Free Report) by 17.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned ...

It has been about a month since the last earnings report for Cencora (COR). Shares have added about 3.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...